Rett syndrome is a neuro-developmental disorder related to autistic behavior. Persons with autism have previously been found to have hyperpeptiduria. We here report a significantly higher level of peptides in the first fasting morning urine from 53 girls with Rett syndrome (both classical and congenital) compared with 53 healthy girls. This elevation in urinary peptides was similar to that in 35 girls with infantile autism. As in persons with autism, the individual levels of urinary peptides in the Rett syndrome group varied, and about a fifth were within the normal range. Levels of peptides were lower in girls with classic Rett syndrome than in girls with congenital Rett syndrome. This may be due to different etiological causes or to active and stagnant phases of the disease. Urine from girls with Rett syndrome was found to have higher frequency and higher levels of some urinary peptides that may cause inhibition of brain maturation and epilepsy.
ABASSI, Z. , GOLOMB, E. & KEISER, H .R. (1992) ‘Neutral Endopeptidase Inhibition Increases Urinary Secretion and Plasma Level of Endothelin’, Metabolism41: 683-685.
2.
AMIR, R .E. , VAN DEN VEYVER, I .B., WAN, M., TRAN, C.Q., FRANCKE, U. & ZOGHBI, H .Y. (1999) ‘Rett Syndrome Is Caused by Mutation in X-Linked MECP2, Encoding Methyl-CpG-Binding Protein 2’, Nature Genetics23: 185-188.
3.
BANKS, W.A. , KASTIN, A .J., HARRISON, L .M. & ZADINA, J.E. (1996) ‘Perinatal Treatment of Rats with Opiates Affects the Development of the Blood-Brain Barrier Transport System PTS-1’, Neurotoxical Teratology18 (6): 711-715.
4.
BELICHENKO, P.V. , HAGBERG, B. & DAHLSTRÖM, A. (1997) ‘Morphological Study of Neocortical Areas in Rett Syndrome’, Acta Neuropathologica93: 50-61.
5.
BIENVENU, T. , CARRIE, A., DE ROUX, N., VINET, M.-C., JONVEAUX, P., COUVERT, P., VILLARD, L., ARZIMANOGLOU, A., BELDJORD, C., FONTES, M., TARDIEN, M. & CHELLY, J. (2000) ‘MeCP2 Mutations Account for Most Cases of Typical Forms of Rett Syndrome’, Human Molecular Genetics9: 1377-1384.
6.
BÖHLEN, P. , CASTILLO, F., LING, R. & GUILLEMIN, R. (1980) ‘Purification of Peptides: An Efficient Procedure for the Separation of Peptides from Amino Acids and Salts’, Int. J. Pept. Prot. Res.16: 306-310.
7.
CADE, R. , PRIVETTE, M., FREGLY, M., ROWLAND, N., ZON, Z., ZELE, V., WAGEMAKER, H.ET AL. (2000) ‘Autism and Schizophrenia: Intestinal disorders’, Nutritional Neuroscience3: 57-72.
8.
EHRMISCH, A. , BRUST, P., KRETZCHMAR, R. & BUHLE, H.-J. (1983) ‘On the Blood-Brain Barrier to Peptides (3H) Beta-Casomorphin-5 Uptake by Eighteen Brain Regions in vivo’, Journal of Neurochemistry41: 1229-1233.
9.
ENGERSTRÖM, I .W. (1992) ‘Age-Related Occurrence of Signs and Symptoms in the Rett Syndrome’, Brain Development14 (supp.): S11-S20.
10.
GSCHANES, A. & WINDISCH, M. (1999) ‘Early Postnatal Treatment with Peptide Preparations Influences Spatial Navigation of Young and Adult Rats’, Behav. Brain Research100 (1-2): 161-166.
11.
HAGBERG, B. (1995) ‘Rett Syndrome: Clinical Peculiarities and Biological Mysteries’, Acta Paediatrica84: 971-976.
12.
HAGBERG, B. & SKJELDAL, O.H. (1994) ‘Rett Variants: A Suggested Model for Inclusion Criteria’, Pediatr. Neurol.11: 5-11.
13.
HAGBERG, B. , GOUTIERES, F., HANEFELD, F., RETT, A. & WILSON, J. (1985) ‘Rett Syndrome: Criteria for Inclusion and Exclusion’, Brain Development7: 372-373.
14.
HAUSER, K .F. , MCLAUGHLIN, P.J. & ZAGON, I .S. (1987) ‘Endogenous Opioids Regulate Dendritic Growth and Spine Formation in Developing Rat Brain’, Brain Research416 (1): 157-161.
15.
HAUSER, K .F. , MCLAUGHLIN, P.J. & ZAGON, I .S. (1989) ‘Endogenous Opioid Systems and the Regulation of Dendritic Growth and Spine Formation’, J. Comp. Neurol.281 (1): 13-22.
16.
HUPPKE, P. , LACCONE, F., KRAMER, N., ENGEL, W. & HANEFELD, F. (2000) ‘Rett Syndrome: Analysis of MECP2 and Clinical Characterization of 31 Patients’, Human Molecular Genetics9: 1369-1375.
17.
JOHNSTON, M .V. , HOHMANN, C. & BLUE, M .E. (1995) ‘Neurobiology of Rett Syndrome’, Neuropediatrics26 (2): 119-122.
18.
KERR, A .M. (2002) ReH Disorder. In P. HOWLIN & O. UDWIN (eds) Outcomes in Neurodevelopmental and Genetic Disorders, pp. 241-271. Cambridge: Cambridge University Press.
19.
KERR, A .M. & STEPHENSON, J.B.P. (1985) ‘Rett’s Syndrome in the West of Scotland’, British Medical Journal291: 579-582.
20.
KITT, C.A. & WILCOX, B.J. (1995) ‘Preliminary Evidence for Neurodegenerative Changes in the Substantia Nigra of Rett Syndrome’, Neuropediatrics26: 114-118.
21.
LEBOYER, M. , BOUVARD, M .P., RECASENS, C., PHILIPPE, A., GUILLOUD-BATAILLE, BONDOUX, D.ET AL. (1994) ‘Difference between Plasma N- and C-Terminal Directed -Endorphin Immunoreactivity in Infantile Autism’, American Journal of Psychiatry151: 1797-1801.
22.
LORBER, B.A. , FREITAG, S .K. & BARTOLOME, J.V. (1990) ‘Effects of Beta-Endorphin on DNA Synthesis in Brain Regions of Preweanling Rats’, Brain Research531: 329-332.
23.
LUNDE, H. , SJAASTAD, Ø. & GJESSING, L .R. (1982) ‘Homocarnosinosis: Homocarnosinurura’, Journal of Neurochemistry38: 238-246.
24.
MURAKAMI, J.W. , COURCHESNE, E., HAAS, R .H. & YEUNG-COURCHESNE, R. (1992) ‘Cerebellar and Cerebral Abnormalities in Rett Syndrome: A Quantitative MR Analysis’, American Journal of Radiology159: 177-183.
25.
MYARA, I. , CHARPENTIER, C. & LEMONNIER, A. (1984) ‘Prolidase and Prolidase Deficiency’, Life Sciences34 (21): 1985-1998.
26.
PAIER, B. , WINDISCH, M. & EGGENREICH, U. (1992) ‘Postnatal Administration of Two Peptide Solutions Affects Passive Avoidance Behaviour of Young Rats’, Behav. Brain Research51 (1): 23-28.
27.
REICHELT, K .L. , HOLE, K., HAMBERGER, A., SAELID, G., EDMINSON, P.D., BRAESTRUP, C.B., LINGJAERDE, O., LEDAAL, P. & ORBECK, H. (1981) ‘Biologically Active Peptide-Containing Fractions in Schizophrenia and Childhood Autism’, Advances in Biochemical Psychopharmacology28: 627-643.
28.
REICHELT, K .L. , EKREM, J. & SCOTT, H. (1990) ‘Gluten, Milk Proteins and Autism: Results of Dietary Intervention on Behavior and Urinary Peptide Excretion’, Journal of Applied Nutrition42: 1-11.
29.
REICHELT, K .L. , KNIVSBERG, A.-M., LIND, G. & NOEDLAND, M. (1991) ‘Probable Etiology and Possible Treatment of Autism’, Brain Dysfunction4: 308-319.
30.
REICHELT, W.H. & REICHELT, K .L. (1997) ‘The Possible Role of Peptides Derived from Food Proteins in Diseases of the Nervous System in Epilepsy and Other Neurological Disorders in Coeliac Disease’, in G. GOBBI (ed.) pp. 227-237.
31.
REICHELT, W.H. , KNIVSBERG, A.-M., NOEDLAND, M., STENSRUD, M. & REICHELT, K .L. (1997) ‘Urinary Peptide Levels and Patterns in Autistic Children from Seven Countries, and the Effect of Dietary Intervention after 4 Years’, Developmental Brain Dysfunction10: 44-55.
32.
REICHELT, W.H. , EK, J., STENSRUD, M. & REICHELT, K .L. (1998) ‘Peptide Excretion in Celiac Disease’, Journal of Pediatric Gastroenterology & Nutrition26: 305-309.
33.
RETT, A. (1966) ‘On an Unusual Brain Atrophy Syndrome in Hyperammonemia in Childhood’, Wien Med. Wochenschr.116 (37): 723-726.
34.
SHANAHAN, M .R. , VENTURINI, A .J., DAISS, J.J. & FRIEDMAN, A .E. (2000) ‘Peptide Diagnostic Markers for Human Disorders’, European Patent Application EP 0 069 015 A2, pp. 1-43.
35.
SHATTOCK, P. , KENNEDY, A., ROWELL, F. & BERNEY, T. (1990) ‘Role of Neuropeptides in Autism and their Relationships with Classical Neurotransmitters’, Brain Dysfunction3: 328-345.
36.
STORM, H. , STOLTENBERG, L., ØYASAETER, S., SAUGSTAD, O.D., ROGNUM, T.O. & REICHELT, K .L. (1995) ‘ -Endorphin May Be a Mediator of Apnea Induced by the Laryngeal Chemoreflex in Piglets’, Pediatric Research38 (2): 205-210.
37.
WAN, M. , LEE, S .S., ZHANG, X., HOUWINK-MANVILLE, I., SONG, H .R., AMIR, R .E., BUDDEN, S., NAIDU, S., PEREIRA, J.L., LO, I .F., ZOGHBI, H .Y., SCHANEN, N.C. & FRANCKE, U. (1999) ‘Rett Syndrome and Beyond: Recurrent Spontaneous and Familial MECP2 Mutations at CpG Hotspots’, American Journal of Human Genetics65 (6): 1520-1529.
38.
WATANABE, Y. , KOJIMA-KUMATSU, I., IWAKI-EGAWA, S. & FUJIMOTO, Y. (1993) ‘Increased Excretion of Proline-Containing Peptides in Dipeptidyl Peptidase IVDeficient Rats’, Res. Comm. Chem. Pathol. Pharmacol.81: 323-350.
39.
ZAGON, I .S. & MCLAUGHLIN, P.J. (1984) ‘Naltrexone Modulates Body and Brain Development in Rats: A Role for Endogenous Opioid Systems in Growth’, Life Sciences35: 2057-2064.
40.
ZAGON, I .S. & MCLAUGHLIN, P.J. (1987) ‘Endogenous Opioid Systems Regulate Cell Proliferation in the Developing Rat Brain’, Brain Research412: 68-72.
